BioSpace News Archive

It was yet another busy week for clinical trial news, with a range of studies for COVID-19, various cancers, fungal infections and other indications.

Invacare Corporation (NYSE: IVC) (“Invacare” or the “company”) announces that it will release its financial results for the first quarter ended March 31, 2022, after the market closes on Monday, May 9, 2022.

Ginkgo Bioworks, the leading horizontal platform for cell programming, announced plans to significantly expand its platform capabilities in agricultural biologicals, from discovery to field.

Bayer announced that the company is pursuing an agreement whereby Ginkgo Bioworks will acquire Bayer’s West Sacramento Biologics Research & Development site and internal discovery and lead optimization platform.

Opthea Limited today announced the appointment of Mr. Quinton Oswald and Dr. Susan Orr to its Board of Directors, effective immediately following election at a General Meeting of Shareholders on April 21st , 2022.

Medexus Pharmaceuticals (Medexus) (TSX: MDP) (OTCQX: MEDXF) and medac, a strategic partner of Medexus, are pleased to announce that medac has resubmitted its New Drug Application for Treosulfan (NDA) with the U.S. Food and Drug Administration (FDA).

Co-Diagnostics, Inc. (Nasdaq: CODX) (the “Company” or “Co-Dx,”), a molecular diagnostics company with a unique, patented platform for the development of molecular diagnostic tests, announced today that it will be hosting a booth at the upcoming 32nd European Congress of Clinical Microbiology & Infectious Diseases (ECCMID), held April 23-26, 2022, in Lisbon, Portugal.

CEL-SCI Corporation announced that two abstracts related to CEL-SCI’s pivotal Phase 3 head and neck cancer clinical trial were accepted at the American Society of Clinical Oncology meeting being held June 3-7, 2022 in Chicago, IL.

InSitu Biologics is very pleased to announce the appointment of Dr. M. Yaman, FRCS, FACS, to its Medical Advisory Board.

Royal Philips, a global leader in health technology, announced that its subsidiary Philips Respironics is notifying customers of its V60/V60 Plus and V680 ventilators about a potential issue with the electrical circuit in these ventilators that controls the 35V power supply to the ventilator and alarm.